Method for detection of coenzyme Q10
US-10114013-B2 · Oct 30, 2018 · US
US11209422B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11209422-B2 |
| Application number | US-201816138786-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 21, 2018 |
| Priority date | Mar 2, 2012 |
| Publication date | Dec 28, 2021 |
| Grant date | Dec 28, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides methods for rapid and quantitative extraction and detection of coenzyme Q10 in a sample readily adaptable to high throughput screening methods. The invention further provides reagents and kits for practicing the methods of the invention.
Opening claim text (preview).
What is claimed is: 1. An isotopically labeled analog of the oxidized form of coenzyme Q10 CoQ10-d6 of the following formula: 2. An isotopically labeled analog of the reduced form of coenzyme Q10 CoQ10H 2 -d6 of the following formula: 3. A mixture for analysis by LC/MS/MS comprising a biological sample and the isotopically labeled analog of claim 1 . 4. The mixture of claim 3 , wherein said biological sample is a bodily fluid. 5. The mixture of claim 4 , wherein said bodily fluid is blood. 6. The mixture of claim 3 , wherein said biological sample is serum. 7. The mixture of claim 3 , wherein said biological sample is plasma. 8. The mixture of claim 3 , wherein said biological sample is a human sample. 9. A mixture for analysis by LC/MS/MS comprising a biological sample and the isotopically labeled analog of claim 2 . 10. The mixture of claim 9 , wherein said biological sample is a bodily fluid. 11. The mixture of claim 10 , wherein said bodily fluid is blood. 12. The mixture of claim 9 , wherein said biological sample is serum. 13. The mixture of claim 9 , wherein said biological sample is plasma. 14. The mixture of claim 9 , wherein said biological sample is a human sample.
Methods for using particle spectrometers · CPC title
Chemical aspects of mass spectrometric analysis of biological material · CPC title
Non-radioactive isotope labels, e.g. for detection by mass spectrometry · CPC title
involving vitamins {or their receptors} · CPC title
Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.